• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Metastatic basal cell carcinoma with a high tumor mutational burden that achieved complete response with pembrolizumab.

作者信息

Yamakawa Kohei, Ogata Dai, Hiki Kojiro, Jinnai Shunichi, Namikawa Kenjiro, Takahashi Akira, Yamazaki Naoya

机构信息

Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan.

出版信息

Int J Dermatol. 2023 Feb;62(2):e79-e80. doi: 10.1111/ijd.16245. Epub 2022 May 12.

DOI:10.1111/ijd.16245
PMID:35553058
Abstract
摘要

相似文献

1
Metastatic basal cell carcinoma with a high tumor mutational burden that achieved complete response with pembrolizumab.具有高肿瘤突变负荷的转移性基底细胞癌，使用帕博利珠单抗治疗后达到完全缓解。
Int J Dermatol. 2023 Feb;62(2):e79-e80. doi: 10.1111/ijd.16245. Epub 2022 May 12.
2
Anti-PD-1 Therapy Leads to Near-Complete Remission in a Patient with Metastatic Basal Cell Carcinoma.抗 PD-1 治疗导致转移性基底细胞癌患者近乎完全缓解。
Oncol Res Treat. 2018;41(6):391-394. doi: 10.1159/000487084. Epub 2018 May 3.
3
Persistence of superficial basal cell carcinoma during pembrolizumab treatment for metastatic melanoma.帕博利珠单抗治疗转移性黑色素瘤期间浅表基底细胞癌持续存在。
Eur J Dermatol. 2021 Feb 1;31(1):99-100. doi: 10.1684/ejd.2020.3958.
4
[Regression of cutaneous basal cell and squamous cell carcinoma under pembrolizumab].[帕博利珠单抗治疗下皮肤基底细胞癌和鳞状细胞癌的消退]
Ann Dermatol Venereol. 2020 Apr;147(4):279-284. doi: 10.1016/j.annder.2019.10.031. Epub 2019 Dec 23.
5
Complete Remission of Basal Cell Carcinoma Following Treatment With Cemiplimab After 2 Years.使用西米普利单抗治疗2年后基底细胞癌完全缓解
JAMA Dermatol. 2021 Aug 1;157(8):1004-1006. doi: 10.1001/jamadermatol.2021.2206.
6
Appearance of New Cutaneous Superficial Basal Cell Carcinomas during Successful Nivolumab Treatment of Refractory Metastatic Disease: Implications for Immunotherapy in Early Versus Late Disease.在纳武单抗成功治疗难治性转移性疾病期间出现新的皮肤浅表基底细胞癌：对早期与晚期疾病免疫治疗的启示
Int J Mol Sci. 2017 Jul 31;18(8):1663. doi: 10.3390/ijms18081663.
7
Pembrolizumab for advanced basal cell carcinoma: An investigator-initiated, proof-of-concept study.帕博利珠单抗治疗晚期基底细胞癌：一项研究者发起的概念验证研究。
J Am Acad Dermatol. 2019 Feb;80(2):564-566. doi: 10.1016/j.jaad.2018.08.017. Epub 2018 Aug 24.
8
Coincident Metastatic Melanoma and Merkel Cell Carcinoma with Complete Remission on Treatment with Pembrolizumab.同时发生的转移性黑色素瘤和默克尔细胞癌经派姆单抗治疗后完全缓解
Acta Derm Venereol. 2017 Nov 15;97(10):1252-1254. doi: 10.2340/00015555-2757.
9
Lasting response after discontinuation of cemiplimab in a patient with locally advanced basal cell carcinoma.局部晚期基底细胞癌患者停用西米普利单抗后的持久反应。
Clin Exp Dermatol. 2021 Dec;46(8):1612-1614. doi: 10.1111/ced.14804. Epub 2021 Jul 29.
10
Rapid response of metastatic cutaneous squamous cell carcinoma to pembrolizumab in a patient with xeroderma pigmentosum: Case report and review of the literature.一名着色性干皮病患者的转移性皮肤鳞状细胞癌对派姆单抗的快速反应：病例报告及文献复习
Eur J Cancer. 2017 Sep;83:99-102. doi: 10.1016/j.ejca.2017.06.022. Epub 2017 Jul 19.

引用本文的文献

1
Immunotherapy for locally advanced and metastatic basal cell carcinoma: a narrative review.局部晚期和转移性基底细胞癌的免疫治疗：一项叙述性综述。
Transl Cancer Res. 2024 Nov 30;13(11):6565-6575. doi: 10.21037/tcr-24-742. Epub 2024 Nov 6.
2
Immunotherapy and Its Timing in Advanced Basal Cell Carcinoma Treatment.晚期基底细胞癌治疗中的免疫疗法及其时机选择
Dermatol Pract Concept. 2023 Oct 1;13(4):e2023252. doi: 10.5826/dpc.1304a252.